Glenn E. Palomaki

发表

Table 16, KQs: Summary of available studies and strength of evidence for four outcomes and all PCA3 comparators

David J Samson, Naomi Aronson, Steven Gutman, 2013 .

Figure 3, PRISMA diagram for selection of published studies

David J Samson, Naomi Aronson, Steven Gutman, 2013 .

Figure J1, A schematic showing the impact of partial verification bias on the sensitivity and false positive rate for total PSA (tPSA) and prostate biopsy

David J Samson, Naomi Aronson, Steven Gutman, 2013 .

[Table], Selected Test Manufacturers for Contact

David J Samson, Naomi Aronson, Linda A Bradley, 2013 .

[Table], Contact Information

David J Samson, Naomi Aronson, Linda A Bradley, 2013 .

DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study

Stanley F. Nelson, Wayne W. Grody, Glenn E. Palomaki, 2012, Genetics in Medicine.

Three-year experience of a CAP/ACMG methods-based external proficiency testing program for laboratories offering DNA sequencing for rare inherited disorders

Elaine Lyon, Felicitas L. Lacbawan, Glenn E. Palomaki, 2013, Genetics in Medicine.

Dna Sequencing of Maternal Plasma to Detect Down Syndrome: An International Clinical Validation Study

Stanley F. Nelson, Wayne W. Grody, Glenn E. Palomaki, 2012 .

Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel

Victoria M. Pratt, Michael S. Watson, Wayne W. Grody, 2004, Genetics in Medicine.

Maternal serum α-fetoprotein, age, and Down syndrome risk

Glenn E. Palomaki, J. Haddow, G. Palomaki, 1987 .